american diabetes association pancreatitis history glp-1 receptor agonist Glucagon-Like Peptide-1 Agonists Use... : Journal of Gastroenterology Nutritional priorities to support GLP-1

The association between glucose-dependent insulinotropic polypeptide and/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: a real-world data analysis

So the argument to be made is using the lowest GLP-1 dose possible to elicit gradual weight loss over time while optimizing diet, resistance exercise, etc

These medications do more than help people lose weight

This is exactly why physician supervision and personalized nutritional guidance are not optional add-ons

8 Cost The high cost of these medications is a barrier to many patients continuing them, with US list prices or $12,000-16,000 per year, and over $6500 a year at maximum discount

This approach ensured a nuanced understanding of the genetic and demographic diversity in the cohort, enabling robust and reliable biomedical research